Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Zymergen Inc. (ZY : NSDQ)

• Company Description    Zymergen Inc. is a biofacturing company. It design, develop and manufacture bio-based breakthrough products. Zymergen Inc. is based in EMERYVILLE, Calif. Number of Employees: 507

• Price / Volume Information    Yesterday's Closing Price: $1.27 Daily Weekly Monthly 20 Day Moving Average: 1,471,489 shares Shares Outstanding: 103.14 (millions) Market Capitalization: $130.99 (millions) Beta: 52 Week High: $46.05 52 Week Low: $1.20 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -28.65% -21.88% 12 Week -67.93% -63.96% Year To Date -81.02% -76.81%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5980 HORTON STREET SUITE 105 - EMERYVILLE,CA 94608 USA ph: 415-801-8073 fax: - investors@zymergen.com http://www.zymergen.com

• General Corporate Information    Officers Jay Flatley - Chairman and Acting Chief Executive Officer Enakshi Singh - Chief Financial Officer Sandra E. Peterson - Lead Independent Director Steven Chu - Director Christine M. Gorjanc - Director Peer Information Zymergen Inc. (CSBHY) Zymergen Inc. (ARWM) Zymergen Inc. (FUL) Zymergen Inc. (IAX) Zymergen Inc. (AVD) Zymergen Inc. (ASH) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: CHEM-SPECIALTY Sector: Basic Materials CUSIP: 98985X100 SIC: 8731 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/15/22 Share - Related Items Shares Outstanding: 103.14 Most Recent Split Date: (:1) Beta: Market Capitalization: $130.99 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.75 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.87 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 13.78% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/15/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.38 Price/Cash Flow: - Price / Sales: 7.36 EPS Growth vs. Year Ago Period: 89.25% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: 28.27% vs. Previous Quarter: 57.65% ROE 03/31/22 - -72.62 12/31/21 - -213.99 09/30/21 - - ROA 03/31/22 - -52.39 12/31/21 - -64.50 09/30/21 - -72.68 Current Ratio 03/31/22 - 4.00 12/31/21 - 5.54 09/30/21 - 4.28 Quick Ratio 03/31/22 - 3.93 12/31/21 - 5.46 09/30/21 - 4.23 Operating Margin 03/31/22 - -1,834.70 12/31/21 - -2,024.89 09/30/21 - -1,746.57 Net Margin 03/31/22 - -1,962.56 12/31/21 - -2,160.81 09/30/21 - -1,831.95 Pre-Tax Margin 03/31/22 - -1,962.46 12/31/21 - -2,160.51 09/30/21 - -1,831.81 Book Value 03/31/22 - 3.34 12/31/21 - 3.99 09/30/21 - 4.66 Inventory Turnover 03/31/22 - 10.09 12/31/21 - 11.68 09/30/21 - 14.24 Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©